QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
39 views
Using public data from GTEx (normal tissue), GEO, cancer collections and more, you'll learn how to use Omicsoft Lands to:
• Investigate a drug target or biomarker expression across different normal tissues, disease conditions, treatments and more
• Correlate the expression of two or more genes
• Identify a list of genes or biomarkers specific to treatment, disease, normal tissue, cell type and more
Using findings from peer-reviewed publications and other sources, we'll explore with you how to use QIAGEN IPA to:
• Study the impact of targeting a gene/protein on different toxicological and biological functions
• Derive toxicity findings for a gene of interest from QIAGEN IPA's knowledgebase
• Identify and study toxicity-related pathways, regulators and functions for an internal dataset or a public dataset
• Compare different drug treatments, other conditions or multi-omics data for novel discoveries
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors in the context of biomarkers, drug targets and pathways
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Human-certified ‘omics data to power drug discovery
Integrating external and internal ‘omics data is a key element of hypothesis...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug Target and Biomarker Investigation using OmicSoft OncoLand
In this 90-minute training, attendees will learn how to use basic expression...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN Ingenuity Pathway Analysis...
In this 90-minute training, users will learn how to do drug treatment,...